Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06627634
Status:
RECRUITING
Last Update Posted:
None
First Post:
2023-05-03
Brief Title:
Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Gastric Cancer and Oligometastatic Liverinvolvement Metastatectomy and Impact on Survival
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LEVECA
Brief Summary:
Offering treatment with potential to cure for participants with no such offer in todays standard treatment options by offering metastatectomia and standard treatment with intention to cure ie neoadjuvant chemotherapy and gastrectomy for participants with gastric- og gastroeusofageal junction cancer Including 20 participants from all 4 centres in Denmark able to perform the surgical procedures in question
Endpoints 2-year overall survival
Endpoints 2-year overall survival
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None